CXCL8 and prostate carcinoma: As noted previously, Egr1 and Egr3 bind to similar sequence motifs on promoters and it is therefore unsurprising that they share a set of target genes such as IL6 and IL8, which we have now validated as direct targets for Egr3 in prostate cancer cells.